Dan Calugaru
Dan Calugaru
UMF Cluj-Napoca
mail.dntcj.ro üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Intravitreal bevacizumab in acute central/hemicentral retinal vein occlusions: three-year results of a prospective clinical study
D Călugăru, M Călugăru
Journal of Ocular Pharmacology and Therapeutics 31 (2), 78-86, 2015
562015
Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with macular edema secondary to vein occlusion
M Mimouni, O Segev, D Dori, N Geffen, V Flores, O Segal
American Journal of Ophthalmology 182, 160-167, 2017
47*2017
Pro-permeability factors in diabetic macular edema; the diabetic macular edema treated with Ozurdex trial
PA Campochiaro, G Hafiz, TA Mir, AW Scott, I Zimmer-Galler, SM Shah, ...
American journal of ophthalmology 168, 13-23, 2016
402016
Characterisation of human non-proliferative diabetic retinopathy using the fractal analysis
Ş Ţălu, DM Călugăru, CA Lupaşcu
International journal of ophthalmology 8 (4), 770, 2015
372015
Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab
LC Olmos, MS Sayed, AL Moraczewski, SJ Gedde, PJ Rosenfeld, W Shi, ...
Eye 30 (3), 463-472, 2016
362016
Long-term efficacy and safety of intravitreal dexamethasone implant for the treatment of diabetic macular edema
F Matonti, S Pommier, F Meyer, C Hajjar, PY Merite, E Parrat, H Rouhette, ...
European Journal of Ophthalmology 26 (5), 454-459, 2016
322016
Vision outcomes following anti–vascular endothelial growth factor treatment of diabetic macular edema in clinical practice
NM Holekamp, J Campbell, A Almony, H Ingraham, S Marks, ...
American journal of ophthalmology 191, 83-91, 2018
302018
Bevacizumab treatment of macular edema in CRVO and BRVO: long-term follow-up.(BERVOLT study: Bevacizumab for RVO long-term follow-up)
T Kornhauser, R Schwartz, M Goldstein, M Neudorfer, A Loewenstein, ...
Graefe's Archive for Clinical and Experimental Ophthalmology 254 (5), 835-844, 2016
212016
Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the USA
AJ Lotery, S Regnier
Eye 29 (3), 380-387, 2015
20*2015
Aflibercept in diabetic macular edema refractory to previous bevacizumab: outcomes and predictors of success
R Laiginhas, MI Silva, V Rosas, S Penas, VA Fernandes, A Rocha-Sousa, ...
Graefe's Archive for Clinical and Experimental Ophthalmology 256 (1), 83-89, 2018
192018
Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled …
X Li, N Wang, X Liang, G Xu, XY Li, J Jiao, J Lou, Y Hashad, ...
Graefe's Archive for Clinical and Experimental Ophthalmology 256 (1), 59-69, 2018
162018
Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusion
K Januschowski, N Feltgen, A Pielen, B Spitzer, M Rehak, G Spital, ...
Graefe's Archive for Clinical and Experimental Ophthalmology 255 (3), 457-462, 2017
15*2017
Analysis of normal human retinal vascular network architecture using multifractal geometry
Ş Ţălu, S Stach, DM Călugăru, CA Lupaşcu, SD Nicoară
International journal of ophthalmology 10 (3), 434, 2017
142017
Conversion to aflibercept after prior anti-VEGF therapy for persistent diabetic macular edema
D Călugăru, M Călugăru
American journal of ophthalmology 168, 290-291, 2016
142016
Comparison of time to retreatment and visual function between ranibizumab and aflibercept in age-related macular degeneration
D Călugăru, M Călugăru
American journal of ophthalmology 100 (174), 181-182, 2017
112017
Long-Term Results of Pro Re Nata Regimen of Aflibercept Treatment in Persistent Neovascular Age-Related Macular Degeneration.
D Călugăru, M Călugăru
American journal of ophthalmology 173, 145, 2017
112017
Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study
D Călugăru, M Călugăru
American journal of ophthalmology 159 (3), 607-608, 2015
112015
Risk factors in central retinal vein occlusion
M Calugaru, Dan
Oftalmologia (Bucharest) 55 (2), 27-37, 1990
11*1990
High-frequency aflibercept injections in persistent neovascular age-related macular degeneration
IK Muftuoglu, FF Tsai, R Gaber, M Alam, A Meshi, WR Freeman
Graefe's Archive for Clinical and Experimental Ophthalmology 255 (4), 709-717, 2017
92017
Prevention of neovascular glaucoma
D Călugăru, M Călugăru
Ophthalmology 120 (7), 1507-1508. e2, 2013
92013
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20